Dr. Stephanie Venn-Watson is Co-Founder and CEO of Seraphina Therapeutics, a health and wellness company that develops groundbreaking essential fatty acid products to help people age healthier. Stephanie is a veterinary epidemiologist and the world’s leading expert on C15:0, the first essential fatty acid to be discovered in over 90 years. Stephanie previously served as an epidemiologist for the World Health Organization and U.S. Navy. With over 60 patents and 80 peer-reviewed scientific publications, her novel approach to discovering nutrient-based therapeutics has been featured on NPR’s Science Friday, CBS, BBC, and National Geographic. Stephanie has been awarded the Department of Health and Human Services Secretary’s Award for Innovations in Disease Prevention and Health Promotion and Boehringer Ingelheim’s Innovation Award. Seraphina won Nutritional Outlook Magazine’s Best of the Industry award, as well as having been recognized as a Fast Company World Changing Idea for its pure C15:0 ingredient.